These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 23098359

  • 1. Effects of low-dose fluticasone propionate/salmeterol combination therapy on exhaled nitric oxide and nitrite/nitrate in breath condensates from patients with mild persistent asthma.
    Pasha MA, Smith TC, Feustel PJ, Jourd'heuil D.
    J Asthma; 2013 Feb; 50(1):64-70. PubMed ID: 23098359
    [Abstract] [Full Text] [Related]

  • 2. Comparison of high-dose salmeterol/fluticasone and moderate-dose salmeterol/fluticasone plus low-dose mometasone in patients with severe persistent asthma.
    Kurashima K, Kagiyama N, Takayanagi N, Sugita Y.
    Respirology; 2011 Jul; 16(5):784-9. PubMed ID: 21382132
    [Abstract] [Full Text] [Related]

  • 3. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 4. Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma.
    Renzi PM, Howard LA, Ortega HG, Ahmad FF, Chapman KR.
    Respir Med; 2010 Apr; 104(4):510-7. PubMed ID: 19944581
    [Abstract] [Full Text] [Related]

  • 5. Role of add-on zileuton on total exhaled, large airway, and small airway/alveolar nitric oxide in moderate-severe persistent adult asthmatics on fluticasone 250 microg/Salmeterol 50 microg.
    Gelb AF, Taylor CF, Simmons M, Shinar C.
    Pulm Pharmacol Ther; 2009 Dec; 22(6):516-21. PubMed ID: 19467341
    [Abstract] [Full Text] [Related]

  • 6. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.
    Fardon T, Haggart K, Lee DK, Lipworth BJ.
    Respir Med; 2007 Jun; 101(6):1218-28. PubMed ID: 17178217
    [Abstract] [Full Text] [Related]

  • 7. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 8. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 9. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
    Currie GP, Syme-Grant NJ, McFarlane LC, Carey FA, Lipworth BJ.
    Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
    [Abstract] [Full Text] [Related]

  • 10. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 11. Salmeterol and fluticasone in young children with multiple-trigger wheeze.
    Mäkelä MJ, Malmberg LP, Csonka P, Klemola T, Kajosaari M, Pelkonen AS.
    Ann Allergy Asthma Immunol; 2012 Jul 29; 109(1):65-70. PubMed ID: 22727160
    [Abstract] [Full Text] [Related]

  • 12. Effect of fluticasone propionate-salmeterol therapy on seasonal changes in airway responsiveness and exhaled nitric oxide levels in patients with pollen-induced asthma.
    Prieto L, Gutiérrez V, Pérez-Francés C, Badiola C, Lanuza A, Bruno L, Ferrer A.
    Ann Allergy Asthma Immunol; 2005 Nov 29; 95(5):452-61. PubMed ID: 16312168
    [Abstract] [Full Text] [Related]

  • 13. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma.
    Currie GP, Stenback S, Lipworth BJ.
    Br J Clin Pharmacol; 2003 Jul 29; 56(1):11-7. PubMed ID: 12848770
    [Abstract] [Full Text] [Related]

  • 14. Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma.
    Mehta V, Stokes JR, Berro A, Romero FA, Casale TB.
    Ann Allergy Asthma Immunol; 2009 Jul 29; 103(1):31-7. PubMed ID: 19663124
    [Abstract] [Full Text] [Related]

  • 15. Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients.
    Gelb AF, Taylor CF, Shinar CM, Gutierrez CA, Zamel N.
    Can Respir J; 2008 Jul 29; 15(4):193-8. PubMed ID: 18551200
    [Abstract] [Full Text] [Related]

  • 16. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
    Schermer TR, Albers JM, Verblackt HW, Costongs RJ, Westers P.
    Fam Pract; 2007 Apr 29; 24(2):181-8. PubMed ID: 17251178
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P.
    Respir Med; 2008 May 29; 102(5):665-73. PubMed ID: 18328683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.